Target intelligence / Profile preview

LENG8 antisense RNA 1 (LENG8-AS1)

Target
LENG8-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

LENG8 antisense RNA 1 (LENG8-AS1) is a primate-specific long non-coding RNA (lncRNA) gene that is transcribed as an antisense RNA from the LENG8 locus but does not code for a protein. It is classified as an antisense RNA and belongs to the broader family of long non-coding RNAs. LENG8-AS1 is believed to play a role in the regulation of neuronal identity and central nervous system function, likely through mechanisms typical of lncRNAs such as chromatin remodeling, transcriptional interference, or RNA-mediated gene silencing. There is emerging evidence that LENG8-AS1 and related antisense lncRNAs are involved in neurodegenerative diseases, including Alzheimer's disease, though precise roles and mechanisms remain under investigation. No drugs are currently known to target LENG8-AS1, and it is not considered a conventional therapeutic target such as a receptor, enzyme, or transporter. There are no reported biomarkers or safety concerns directly associated with LENG8-AS1.

Other names
LENG8 antisense RNA 1 (non-protein coding)LENG8-AS1
02

Mechanism of action

Not established for drug targets; as a lncRNA may modulate gene transcription by antisense inhibition or epigenetic modification

03

Biological functions

Regulation of neuronal identityCentral nervous system functionLikely transcriptional regulation or chromatin modification (common for lncRNAs)
04

Disease associations

Possible roles in neurodegenerative diseases (notably Alzheimer's disease)Central nervous system disorders
05

Safety considerations

None known; as a non-coding RNA, not subject to direct pharmacological modulation

Beyond the preview

Go deeper on LENG8 antisense RNA 1 (LENG8-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LENG8 antisense RNA 1 (LENG8-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call